Korean Journal of Psychosomatic Medicine (정신신체의학)

Korean Psychosomatic Society (한국정신신체의학회)
권호 표지
DOI QR코드

DOI QR Code

Psychosocial Characteristics and Quality of Life in Patients with Functional Gastrointestinal Disorder

기능성위장질환 환자들의 정신사회적 특성과 삶의 질

  • Lee, Dong-Ho (Department of Psychiatry, School of Medicine, Wonkwang University) ;
  • Lee, Sang-Yeol (Department of Psychiatry, School of Medicine, Wonkwang University) ;
  • Ryu, Han-Seung (Department of Internal Medicine, School of Medicine, Wonkwang University) ;
  • Choi, Suck-Chei (Department of Internal Medicine, School of Medicine, Wonkwang University) ;
  • Yang, Chan-Mo (Department of Psychiatry, School of Medicine, Wonkwang University) ;
  • Jang, Seung-Ho (Department of Psychiatry, School of Medicine, Wonkwang University)
  • 이동호 (원광대학교 의과대학 정신건강의학교실) ;
  • 이상열 (원광대학교 의과대학 정신건강의학교실) ;
  • 류한승 (원광대학교 의과대학 내과학교실) ;
  • 최석채 (원광대학교 의과대학 내과학교실) ;
  • 양찬모 (원광대학교 의과대학 정신건강의학교실) ;
  • 장승호 (원광대학교 의과대학 정신건강의학교실)
  • Received : 2020.02.08
  • Accepted : 2020.03.23
  • Published : 2020.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : The aim of this study was to compare psychosocial characteristics of the functional gastrointestinal disorders FGID group, non-FGID group, and control group and determine factors affecting the QOL of patients with FGID. Methods : 135 patients diagnosed with FGID were selected. 79 adults had no observable symptoms of FGID (control group) and 88 adults showed symptoms of FGID (non-FGID group). Demographic factors were investigated. The Korean-Beck Depression Inventory-II, Korean-Beck Anxiety Inventory, Korean-Childhood Trauma Questionnaire, Multidimensional Scale of Perceived Social Support, Connor-Davidson Resilience Scale, Patient Health Questionnaire-15 and WHO Quality of Life Assessment Instrument Brief Form were used to assess psychosocial factors. A one-way ANOVA was used to compare differences among groups. Pearson correlation test was performed to analyze the correlation of psychosocial factors and QOL of the FGID group. Further, a hierarchical regression analysis was conducted to determine factors affecting the QOL of the FGID group. Results : Between-group differences were not significant in demographic characteristics. Depression (F=48.75, p<0.001), anxiety (F=14.48, p<0.001), somatization (F=24.42, p<0.001) and childhood trauma (F=12.71, p<0.001) were significantly higher in FGID group than in other groups. Social support (F=39.95, p<0.001) and resilience (F=17.51, p<0.001) were significantly lower in FGID group than in other groups. Resilience (β=0.373, p<0.01) was the most important explanatory variable. The explained variance was 47.2%. Conclusions : Significantly more symptoms of depression, anxiety, childhood trauma, and somatization were observed for the FGID group. This group also had less social support, resilience, and quality of life than the non-FGID and control groups. The key factor for quality of life of the FGID group was resilience.

연구목적 본 연구에서는 FGID 환자군, FGID양성군 및 정상대조군에서 정신사회적 특성을 비교하고, 기능성위장질환 환자의 삶의 질에 영향을 주는 요인을 알아보고자 하였다. 방 법 원광대학교병원 소화기 내과 전문의에 의해 기능성위장질환으로 진단받은 환자135명을 FGID 환자군으로 선정하였다. 167명의 일 도 지역 공무원을 대상으로 로마 III 진단 기준에 따라 기능성위장증상을 보이지 않는 79명을 정상대조군, 기능성위장증상을 나타내는 88명은 FGID 양성군으로 선별하였다. 인구통계학적 요인을 조사하였으며 정신사회적 요인을 평가하기 위해 Korean version of the Beck Depression Inventory-II (K-BDI-II), Korean version of the Beck Anxiety Inventory (K-BAI), Korean version of Childhood Trauma Questionnaire (CTQ-K), Multi-dimensional Scale of Perceived Social Support (MSPSS), Korean Version of Connor-Davidson Resilience Scale (K-CD-RISC), Patient Health Questionnaire-15 (PHQ-15), World Health Organization Quality of Life Assessment Instrument Brief Form (WHOQOL-BREF)를 사용하였다. 일원배치 분산분석(one-way ANOVA)을 사용하여 집단들 간의 차이를 비교하고 FGID 환자군의 삶의 질과 정신사회적 요인들의 상관관계를 분석하기 위해 Pearson correlation test를 시행하였다. FGID 환자군의 삶의 질에 영향을 미치는 요인들을 알아보기 위해 위계적 회귀분석(Hierarchical regression analysis)을 시행하였다. 결 과 우울 증상(F=48.75, p<0.001), 불안(F=14.48, p<0.001), 아동기 트라우마(F=12.71, p<0.001) 및 신체화(F=24.42, p<0.001)에서 FGID 환자군이 다른 두 그룹에 비해 유의하게 점수가 높았다. 사회적지지(F=39.95, p<0.001)와 회복탄력성(F=17.51, p<0.001) 및 삶의 질(F=52.14, p<0.001)에서 FGID 환자군이 다른 두 그룹에 비해 유의하게 점수가 낮았다. Model 2에서는 Model 1에 심리적 변인들을 추가했으며 회복탄력성(β=0.373, p<0.01)이 가장 중요한 설명 변인이었다. 최종 회귀 모델의 설명 변량은 47.2%였다. 결 론 FGID 환자군은 FGID 양성군 및 정상대조군에 비해 우울 증상, 불안과 아동기 트라우마, 신체화가 유의하게 높았으며 사회적지지 및 회복탄력성, 삶의 질이 낮았다. FGID 환자군의 삶의 질에 주요한 요인은 회복탄력성이었다.

Keywords

References

  1. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390. https://doi.org/10.1053/j.gastro.2006.03.008
  2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-1491. https://doi.org/10.1053/j.gastro.2005.11.061
  3. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology 2016;150:1262-1279. https://doi.org/10.1053/j.gastro.2016.02.032
  4. Mayer EA. Emerging disease model for functional gastrointestinal disorders. Am J Med 1999;107:12-19. https://doi.org/10.1016/S0002-9343(99)00277-6
  5. Mayer E, Tillisch K, Bradesi S. Modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther 2006;24:919-933. https://doi.org/10.1111/j.1365-2036.2006.03078.x
  6. Talley N, Fung L, Gilligan I, McNeil D, Piper D. Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause: a case-control study. Gastroenterology 1986;90:886-892. https://doi.org/10.1016/0016-5085(86)90864-4
  7. Karling P, Danielsson A, Adolfsson R, Norrback K. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission. J Neurogastroenterol Motil 2007;19:896-904. https://doi.org/10.1111/j.1365-2982.2007.00967.x
  8. Leserman J, Drossman DA. Relationship of abuse history to functional gastrointestinal disorders and symptoms: some possible mediating mechanisms. Trauma, Violence & Abuse 2007;8:331-343. https://doi.org/10.1177/1524838007303240
  9. Kanuri N, Cassell B, Bruce SE, White KS, Gott BM, Gyawali CP, Sayuk GS. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS). J Neurogastroenterol Motil 2016;28:1508-1517. https://doi.org/10.1111/nmo.12848
  10. Norbeck JS, Lindsey AM, Carrieri VL. The development of an instrument to measure social support. Nurs Res 1981;30:264-269.
  11. Lackner J, Brasel A, Quigley BM, Keefer L, Krasner S, Powell C, Katz L, Sitrin M. The ties that bind: perceived social support, stress, and IBS in severely affected patients. J Neurogastroenterol Motil 2010;22:893-900. https://doi.org/10.1111/j.1365-2982.2010.01516.x
  12. Smith BW, Zautra AJ. Vulnerability and resilience in women with arthritis: test of a two-factor model. J Consult Clin Psychol 2008;76:799. https://doi.org/10.1037/0022-006X.76.5.799
  13. Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a metaanalytic review. Psychosom Med 2003;65:528-533. https://doi.org/10.1097/01.PSY.0000075977.90337.E7
  14. Organization WH. WHOQOL study protocol. Geneva: WHO; 1993.
  15. ElSerag H, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002;16:1171-1185. https://doi.org/10.1046/j.1365-2036.2002.01290.x
  16. Kim SW, Jang SH, Ryu HS, Choi SC, Rho SH, Lee SY. A study on the psychosocial characteristics and quality of life in functional gastrointestinal disorders. Korean J Psychosom Med 2019;27:25. https://doi.org/10.22722/KJPM.2019.27.1.25
  17. Sung H, Kim J, Park Y, Bai D, Lee S, Ahn H. A study on the reliability and the validity of Korean version of the beck depression inventory-II (K-BDI-II). J Korean Soc Biol Ther Psychiatry 2008;14:201-212.
  18. Yook S, Kim Z. A clinical study on the Korean version of beck anxiety inventory: comparative study of patient and non-patient. Korean J Clin Psychol 1997;16:185-197.
  19. Kim D, Park SC, Yang H, Oh DH. Reliability and validity of the Korean version of the childhood trauma questionnaireshort form for psychiatric outpatients. Psychiatry Investig 2011;8:305. https://doi.org/10.4306/pi.2011.8.4.305
  20. Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. J Pers Assess 1988;52:30-41. https://doi.org/10.1207/s15327752jpa5201_2
  21. Shin J, Lee Y. The effects of social supports on psychosocial well-being of the unemployed. Korean J Soc Welf Res 1999;37:241-269.
  22. Connor KM, Davidson JR. Development of a new resilience scale: The Connor-Davidson resilience scale (CD-RISC). Depress Anxiety 2003;18:76-82. https://doi.org/10.1002/da.10113
  23. Baek H, Lee K, Joo E, Lee M, Choi K. Reliability and validity of the Korean version of the Connor-Davidson resilience scale. Psychiatry Investig 2010;7:109. https://doi.org/10.4306/pi.2010.7.2.109
  24. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosomatic Medicine 2002;64:258-266. https://doi.org/10.1097/00006842-200203000-00008
  25. Han C, Pae C, Patkar AA, Masand PS, Kim KW, Joe S, Jung I. Psychometric properties of the patient health questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatients. Psychosomatics 2009;50:580-585. https://doi.org/10.1016/S0033-3182(09)70859-X
  26. Min SK, Lee CI, Kim KI, Suh SY, Kim DK. Development of Korean version of WHO quality of life scale abbreviated version (WHOQOL-BREF). J Korean Neuropsychiatr Assoc 2000;39:571-579.
  27. PintoSanchez MI, Ford AC, Avila CA, Verdu EF, Collins SM, Morgan D, Moayyedi P, Bercik P. Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. Am J Gastroenterol 2015;110:1038. https://doi.org/10.1038/ajg.2015.128
  28. Reidy J, Keogh E. Testing the discriminant and convergent validity of the MASQ using a British sample. Pers Individ Differ 1997;23:337-344. https://doi.org/10.1016/S0191-8869(97)00048-2
  29. Enns MW, Cox BJ, Parker JD, Guertin JE. Confirmatory factor analysis of the beck anxiety and depression inventories in patients with major depression. J Affect Disord 1998;47:195-200. https://doi.org/10.1016/S0165-0327(97)00103-1
  30. Park JH, Rhee P, Kim HS, Lee JH, Kim Y, Kim JJ, Rhee JC, Kang EH, Yu B. Increased ${\beta}$-adrenergic sensitivity correlates with visceral hypersensitivity in patients with constipation-predominant irritable bowel syndrome. Dig Dis Sci 2005;50:1454-1460. https://doi.org/10.1007/s10620-005-2860-x
  31. Geeraerts B, Vandenberghe J, Van Oudenhove L, Gregory LJ, Aziz Q, DuPont P, Demyttenaere K, Janssens J, Tack J. Influence of experimentally induced anxiety on gastric sensorimotor function in humans. Gastroenterology 2005;129:1437-1444. https://doi.org/10.1053/j.gastro.2005.08.020
  32. Drossman DA, Leserman J, Nachman G, Li Z, Gluck H, Toomey TC, Mitchell CM. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med 1990;113:828-833. https://doi.org/10.7326/0003-4819-113-11-828
  33. Levy RL, Olden KW, Naliboff BD, Bradley LA, Francisconi C, Drossman DA, Creed F. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006;130:1447-1458. https://doi.org/10.1053/j.gastro.2005.11.057
  34. O'Malley D, Dinan TG, Cryan JF. Alterations in colonic corticotropin-releasing factor receptors in the maternally separated rat model of irritable bowel syndrome: differential effects of acute psychological and physical stressors. Peptides 2010;31:662-670. https://doi.org/10.1016/j.peptides.2010.01.004
  35. Gosselin R, O'Connor RM, Tramullas M, JulioPieper M, Dinan TG, Cryan JF. Riluzole normalizes early-life stress-induced visceral hypersensitivity in rats: role of spinal glutamate reuptake mechanisms. Gastroenterology 2010;138:2418-2425. https://doi.org/10.1053/j.gastro.2010.03.003
  36. Paykel ES. Life events, social support and depression. Acta Psychiatr Scand 1994;89:50-58. https://doi.org/10.1111/j.1600-0447.1994.tb05803.x
  37. Oxman TE, Hull JG. Social support and treatment response in older depressed primary care patients. J Gerontol B Psychol Sci Soc Sci 2001;56:35-45.
  38. Michalak EE, Wilkinson C, Hood K, Dowrick C, Wilkinson G. Seasonality, negative life events and social support in a community sample. Br J Psychiatry 2003;182:434-438. https://doi.org/10.1192/bjp.182.5.434
  39. Mikolajczak M, Roy E, Luminet O, De Timary P. Resilience and hypothalamic-pituitary-adrenal axis reactivity under acute stress in young men. Stress 2008;11:477-482. https://doi.org/10.1080/10253890701850262
  40. Gupta A, Love A, Kilpatrick LA, Labus JS, Bhatt R, Chang L, Tillisch K, Naliboff B, Mayer EA. Morphological brain measures of cortico-limbic inhibition related to resilience. J Neurosci Res 2017;95:1760-1775. https://doi.org/10.1002/jnr.24007
  41. Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology 2011;140:761-765. https://doi.org/10.1053/j.gastro.2011.01.032
  42. Chang L, Sundaresh S, Elliott J, Anton P, Baldi P, Licudine A, Mayer M, Vuong T, Hirano M, Naliboff B. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. J Neurogastroenterol Motil 2009;21:149-159. https://doi.org/10.1111/j.1365-2982.2008.01171.x
  43. Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998;42:845-849. https://doi.org/10.1136/gut.42.6.845
  44. Wilhelmsen I. Somatization, sensitization, and functional dyspepsia. Scand J Psychol 2002;43:177-180. https://doi.org/10.1111/1467-9450.00284
  45. Lembo T, Naliboff B, Munakata J, Fullerton S, Saba L, Tung S, Schmulson M, Mayer EA. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999;94:1320. https://doi.org/10.1016/S0002-9270(99)00064-7
  46. Creed F, Ratcliffe J, Fernandes L, Palmer S, Rigby C, Tomenson B, Guthrie E, Read N, Thompson DG. Outcome in severe irritable bowel syndrome with and without accompanying depressive, panic and neurasthenic disorders. Br J Psychiatry 2005;186:507-515. https://doi.org/10.1192/bjp.186.6.507
  47. Mikolajczak M, Roy E, Luminet O, de Timary P. Resilience and hypothalamic-pituitary-adrenal axis reactivity under acute stress in young men. Stress 2008;11:477-482. https://doi.org/10.1080/10253890701850262
  48. Delany C, Miller K, ElAnsary D, Remedios L, Hosseini A, McLeod S. Replacing stressful challenges with positive coping strategies: a resilience program for clinical placement learning. Adv Health Sci Educ Theory Pract 2015;20:1303-1324. https://doi.org/10.1007/s10459-015-9603-3